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Abstract
Background: Guinea-Bissau is a small country in West Africa with a population of 1.7 million. The WHO and UNICEF reported
an under-five child mortality of 203 per 1000, the 10th highest amongst 192 countries. The aim of the trial is to assess whether
an intervention package that includes community health promotion campaign and education through health clubs, intensive
training and mentoring of village health workers to diagnose and provide first-line treatment for children's diseases within the
community, and improved outreach services can generate a rapid and cost-effective reduction in under-five child mortality in
rural regions of Guinea-Bissau. Effective Intervention plans to expand the project to a much larger region if there is good
evidence after two and a half years that the project is generating a cost-effective, sustainable reduction in child mortality.
Methods/design: This trial is a cluster-randomised controlled trial involving 146 clusters. The trial will run for 2.5 years. The
interventions will be introduced in two stages: seventy-three clusters will receive the interventions at the start of the project,
and seventy-three control clusters will receive the interventions 2.5 years after the first clusters have received all interventions
if the research shows that the interventions are effective. The impact of the interventions and cost-effectiveness will be
measured during the first stage.
The package of interventions includes a community health promotion campaign and education through health clubs, and
intensive training and mentoring of village health workers to diagnose and provide first-line treatment for common children's
diseases within the community. It also includes improved outreach services to encourage provision of antenatal and post natal
care and provide ongoing monitoring for village health workers.
The primary outcome of the trial will be the proportion of children that die under 5 years of age during the trial. Secondary
outcomes will include age at and cause of child deaths, neonatal mortality, infant mortality, maternal mortality, health knowledge,
health seeking behaviour, morbidity and costs.
Discussion: The trial will be run by research and service delivery teams that act independently, overseen by a trial steering
committee. A data monitoring committee will be appointed to monitor the outcome and any adverse effects.
Trial Registration: Current Controlled Trials ISRCTN52433336
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Background
Research justification and relevant literature
Guinea-Bissau is a small country in West Africa with a
population of 1.7 million. The country is very poor with
GDP per capita at $352 per person. The WHO and
UNICEF report that under-five child mortality is 203 per
1000 in 2004, ranking the 10th highest amongst 192 coun-
tries [1].
A prospective survey conducted during 2003–2005 esti-
mated that under-five child mortality is 308 per 1000 in
rural regions of Guinea-Bissau, with neonatal mortality of
approximately 70 per 1000 [Rodriguez, A., Tome, C: Seg-
uimento e avaliacao de indicadores do plano nacional de
desenvolvimento sanitario e do projecto multisectorial de
luta contra sida. Bandim Health Project, 2006]. Our base-
line survey in the region where this study is to be imple-
mented found an under-five child mortality rate of 154
per 1000 as reported by women aged 12 to 49 for their
2002 to 2007 pregnancy history. While both estimates
suggest very high child mortality, the difference in these
estimates may reflect methodologies (prospective versus
retrospective monitoring of births and deaths) and differ-
ing regional coverage. There is very little information on
the causes of child deaths. The Bellagio Child Survival
Study Group concluded that neonatal deaths in low
income countries were mostly due to sepsis acquired
around and soon after birth, birth asphyxiation, and con-
genital abnormalities. They estimated that diarrhoea,
pneumonia and malaria cause more than three quarters of
child deaths after the neonatal period [2]. The Joint
United Nations Programme on HIV/AIDS estimates a rel-
atively low 1.8% HIV prevalence in Guinea-Bissau in
2007 compared to other Sub-Saharan African countries
where the overall prevalence estimate is around 6% [3].
The high child mortality in rural Guinea-Bissau is likely to
be due to multiple factors. Although most of the diseases
that cause child deaths are probably preventable, low
income and logistics have limited the quality and availa-
bility of public healthcare. Even if clinical services were
improved, poor health knowledge and education and lim-
ited number of trained health personnel, probably con-
tribute to poor treatment seeking practices and
preventable child deaths. Poor roads and remoteness also
make it difficult for guardians to seek care for their chil-
dren.
Research in other settings suggests that an aggressive pro-
gramme of community health promotion, in combina-
tion with mentoring for community health workers, and
improved availability of services and medicines at the
community level, could lead to major, cost-effective
declines in child mortality. As part of complex interven-
tions, women's participatory discussion groups, through a
series of meetings where issues related to safe child birth
and treatment of the neonates were discussed, were
shown to reduce neonatal mortality by 28% in Nepal [4].
In India, home based neonatal care and management of
sepsis by village health workers (men and women with lit-
tle or no health education prior to training) led to a 62%
decline in neonatal mortality in the third year of interven-
tion when compared to a control region that surrounded
the project area. Fatality from sepsis also declined from
16.6% to 2.8% [5]. The Comprehensive Rural Health
Project in India reports that infant mortality fell by
approximately 50% in a period of five years through the
introduction of village health workers, supported by
mobile health clinics and limited clinical services, in iso-
lated rural communities in Maharashtra state [6]. Several
recently published reviews summarise the effects of com-
plex community based interventions on health and child
survival in Asia and Africa [7-9]. These reviews list the var-
ious types of community programmes, taken place until
recently, and report their effectiveness in diverse settings.
This project aims to generate a rapid and broad improve-
ment in community health knowledge and practices pri-
marily through the introduction of community health
clubs, and training and mentoring of village health work-
ers. In order to ensure that basic clinical services discussed
in the education campaigns are available, the project will
also enhance clinical services related to maternal and
child health, and provide outreach services to the commu-
nities.
The interventions planned in this health project cannot all
be introduced at once, and they require an extended
period of intensive training and community involvement.
To ensure unbiased and reliable evaluation of the effect of
the interventions on communities, a randomised control-
led trial involving 146 clusters will be conducted. The
project plans to introduce a two and a half year pro-
gramme of interventions in 73 of the clusters, chosen at
random, covering approximately 40,000 population with
the remaining 73 clusters forming a control group. After
2.5 years the remaining 73 control clusters will receive the
intervention.
In order to understand whether the interventions have an
impact on mortality and are cost-effective, and to maxim-
ise the impact of the interventions in subsequent years, it
is important to carefully measure the outcomes. To
achieve this, the project design includes an intense
research component, during the first two and a half years
of the interventions, which will carefully measure the
impact on maternal and child health and cost-effective-
ness. The results of this research will be used to improve
the expansion of the project as it covers much larger pop-
ulations in subsequent years.BMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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The research component of the study will provide valua-
ble information to health authorities in a region where
there is currently little information. The study will provide
estimates of child and maternal mortality, uptake of serv-
ices, and causes of death in the project area. This informa-
tion should be useful for designing further projects to
improve maternal and child health throughout Guinea-
Bissau.
Background information on the trial area
The Tombali and Quinara regions are in the south of the
country (Figure 1) and have a combined population of
approximately 200,000. They are relatively inaccessible,
with few paved roads and little infrastructure. There is no
public supply of electricity in the region. The main ethnic
groups are Balanta, Biafada and Fula. The most common
spoken language is Kriol, although often only local lan-
guages associated with ethnic groups are spoken. Cash-
ews, rice, palm oil and fruits are the main agricultural
products. There is little industry.
Objectives
The aim of the study is to evaluate the impact of an inter-
vention package including community health promotion
campaign, training and mentoring village health workers,
and improved outreach services ahead of a planned
expansion of the project to a much larger region of rural
Guinea Bissau.
An important element of the trial is to evaluate cost effec-
tiveness and the sustainability of such a programme.
Methods/design
The study is a cluster-randomised trial, where communi-
ties will be randomised at the start of the trial to interven-
tion and control clusters. Control clusters will receive the
interventions approximately 2.5 years after the interven-
tion clusters if the research shows that the interventions
are effective.
Map of Guinea Bissau Figure 1
Map of Guinea Bissau. The trial area:Tombali and Quinara regions are in the south of the country.BMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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Outcomes of the study
The primary outcome of the trial is the proportion of chil-
dren that die under- five during the study period.
Secondary outcomes will include:
- neonatal and infant mortality rates, and the probability
of death under the age of five calculated using life-table
methodology
- age at and cause of child deaths
- treatment practices for sick children
- percentage of mothers who use ORS to treat children
with diarrhoea
- percentage of children who received consultations
with trained personnel when recently sick
- mother's or primary caregiver's knowledge of childhood
diseases and safe delivery
- proportion of mothers with children under-five that
have knowledge of symptoms of dangerous disease;
- proportion of mothers with children under-five that
have knowledge of treatment procedures and medi-
cines usage for diarrhoea, fever, and cough with rapid
breathing
- proportion of women aged 15 to 49 with knowledge of:
- key safe practices related to antenatal care
- symptoms or factors that would imply a pregnant
mother has a high risk of complications at delivery
- need to sterilize instruments used to cut the umbili-
cal cord
- procedures to keep the umbilical cord sterile
- symptoms of neonatal sepsis
- recommended breast feeding practices after delivery
- child morbidity (prevalence of fever, diarrhoea, respira-
tory tract infections)
- maternal mortality rate per 100,000 pregnancies
- age at and cause of maternal deaths
- proportion of deliveries conducted at institutions
- indicators of safe home birthing practices
- proportion of deliveries where trained personnel
were present
- proportion of deliveries where instruments used to
cut the umbilical cord were sterilized
- proportion of deliveries where the belly button was
treated with alcohol or antiseptic solution subsequent
to cutting the umbilical cord
- proportion of deliveries where measures to prevent
hypothermia were taken
- proportion of deliveries where breast-feeding was started
within one hour after birth
- cost effectiveness
Randomisation
Clusters will be stratified according to major ethnic cate-
gories (Balanta, non-Balanta and mixed ethnicity) and to
distance from a regional health centre or hospital (within
walking distance or not). All 146 clusters will be ran-
domly allocated, within these six strata, to either the inter-
vention or control group.
Interventions
Table 1 outlines the activities that each arm of the project
receives during the first two and one half years.
At the start of the intervention, health clubs will be organ-
ised in each community. The number of health clubs will
be chosen so that there are approximately 60 households
per club. These clubs will meet regularly for two years and
cover topics related to maternal and child health that are
expected to impact on child mortality:
 ￿ Recognition, treatment and prevention of malaria,
pneumonia and diarrhoea
 ￿ Safe pregnancy and delivery
 ￿ Care for newborns
 ￿ Hygiene and sanitation
In addition to health clubs, communities will meet at the
start of the interventions to select village health workers.
These village health workers will be members of the
health clubs, and will work closely with health clubs. The
village health workers will be given intensive block train-
ing (3–5 days for each session) by registered nurses,
"nurse trainers", in the following areas:BMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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 ￿ Recognition, treatment and prevention of diarrhoea
 ￿ Recognition, treatment and prevention of malaria
 ￿ Recognition, treatment and prevention of pneumo-
nia
 ￿ Safe pregnancy and delivery
 ￿ Care for the newborn
 ￿ Nutrition and child growth monitoring
The training for these workers will reflect the Ministry of
Health's policies and IMCI recommendations [10].
Village health workers will also attend and help manage
their local health clubs, and they will help coordinate
antenatal and vaccination service provision within the
cluster. They will also assist with home deliveries and
make regular visits to monitor neonates immediately after
birth. They will also provide advice on treatment of sick
children. Once they pass through the relevant stage in
their training, they will be asked to coordinate the provi-
sion of safe delivery kits and child drugs in their health
clubs. Drugs will be provided to treat the major diseases
that cause child deaths in the community. The choice of
drugs provided will reflect national and IMCI policies,
and will be approved by the Ministry of Health.
After each training block, the village health workers will
return to their village and discuss the training in health
clubs. They will also visit with mothers of children who
have symptoms of disease, and discuss the training with
them. Nurse-trainers will visit each village health worker
twice per month to monitor the quality of their work, pro-
vide advice, and reinforce the training. An audit system
will be maintained to keep track of the quality of the vil-
lage health worker's activities along with measuring the
incidence of disease and recommended treatments in
each community.
The nurse trainers will also carry out monthly mobile
clinic visits to villages. The services provided during these
visits will include antenatal care, child health checks, and
treatment for acute disease.
During antenatal care visits, women will be assessed for
risk, and those women that are considered to be at high
risk will be highly encouraged to deliver in a hospital, and
to travel to the hospital prior to delivery. These women
will receive free primary and secondary services at the hos-
pital.
Duration
The trial will run for a period of two and a half years after
the interventions have been fully implemented in the
intervention clusters. All interventions will be given to the
control clusters at the end of the trial if the research shows
that the interventions are effective.
Trial site
The trial site is the region of Tombali and Quinara in the
south of Guinea Bissau. The definition of clusters for the
trial is complicated due to the lack of any accurate maps,
village boundaries or recent population surveys. The last
Table 1: Trial activities by arms of the trial in the first 2.5 years
Activities
Intervention (73 clusters) Control (73 clusters)
Hospitals for caesarean sections and clinics for emergency care are buttressed Hospitals for caesarean sections and clinics for emergency care 
are buttressed: materials from the programme are available to 
controls if needed for emergencies and staff trained in IMCI as 
needed.
Health clubs organized and participants receive:
2 years of training in health issues.
Training and mentoring for several village
health workers, who are members of the
health clubs, in issues related to maternal
and child health.
Maternal and child health outreach
programme operated by 6–8 trained
mentor nurses.
Free institutional deliveries for high risk
mothers and delivery kits to all pregnant
mothers.
Medicines package for children.
Quarterly monitoring surveys Quarterly monitoring surveysBMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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census was conducted in 1991, and since that time there
has been substantial migration due to civil war and socio-
economic factors. The regional departments of health
maintain lists of tabancas where they sometimes provide
outreach services, but they do not have information on
the population of these tabancas, nor maps showing accu-
rate locations.
Defining eligible clusters and mapping households, 
inclusion and exclusion criteria
One hundred and forty six clusters are to be enrolled in
the trial. Clusters have been identified and enumerated
during a baseline survey. Existing lists and maps of Taban-
cas used by the regional departments of health has been
compiled to identify Tabancas. With the help of experts at
the department of health, and visits to the tabancas prior
to conducting the survey, all Tabancas that were believed
to have at least 300 population were considered to be eli-
gible.
If two Tabancas with eligible size were less than 4 km
apart we chose the Tabanca that has the smallest number
of houses but possibly at least 40 houses. Major urban
areas with more than 2000 population were excluded
from the list. Fieldworkers travelled to the region and sur-
veyed the populations in the listed Tabancas, or in
unlisted Tabancas (if they found one not on the list once
in the region). While the interventions will be made avail-
able to all households within a Tabanca, the analysis of
the trial will be based on outcomes for the closest house-
holds to the centre of the Tabanca. The baseline survey
aimed to enumerate an approximate population of 350
for each cluster. With an assumed average of 8 members
per dwelling, the baseline survey aimed to track the near-
est 40–50 dwellings to the health club meeting place.
After defining a central point in the Tabanca, which was
either the USC if it existed or any other central meeting
place if not, field workers stayed in the village to map up
to 52 but if achievable not less than 40 households. They
interviewed all available eligible women within the
households (see below). If there were fewer than 40
dwellings in the Tabanca the fieldworkers were asked to
pick the nearest Tabanca within walking distance from the
first Tabanca and to map additional households until they
had reached a total of 40 but not more than 52 house-
holds. If they still did not reach 40 households, a third
Tabanca was chosen nearby and this procedure contin-
ued. If there was no other eligible Tabanca within walking
distance the fieldworkers were told to stop after mapping
all available households.
After surveying an adequate number of households to
form a cluster (population approximately 350), field
workers travelled to the next nearest eligible Tabanca to
survey. This process resulted in 241 Tabancas forming 146
clusters being eligible for inclusion in the trial.
Women eligible for analysis within clusters
The analysis of the trial will be based on outcomes for eli-
gible women, and children living with them, and on the
outcomes from new pregnancies arising during the trial.
A woman is eligible for inclusion in the analysis of the
trial if:
 ￿ She lives in one of the 146 selected clusters.
 ￿ She is a resident in one of the households mapped
and is interviewed during the baseline survey.
 ￿ She gives consent to participate in the trial.
 ￿ She reports that she is between 12 and 49 years of
age or/and she reports that she is the primary caregiver
for a child under five years of age at the time of the
baseline survey.
 ￿ The tabanca she lives in gives consent to participate
in the trial.
Children eligible for analysis
Children are eligible for inclusion in the analysis if:
 ￿ They are five years of age or younger at the time of
randomisation and they reside permanently with an
eligible women at the time of randomisation, and the
child's name was recorded during the baseline survey,
or
 ￿ They are born (live birth) to an eligible woman after
baseline survey and are alive at the time of randomisa-
tion,
or
 ￿ They are born (live birth) to an eligible woman after
randomisation.
For the primary analysis, the survival of these children will
be considered from 1 April 2008, by which time all main
components of the intervention will have been imple-
mented. This delay is necessary in order to give the imple-
mentation team time to register households for the
intervention and to train personnel, and will also ensure
that the interventions have sufficient time to have an
impact on survival. According to this schedule, the inter-
ventions will start being implemented in control clusters
at the end of September 2010, just after the end of theBMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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rainy season in the region (if the research shows that the
interventions are effective). For the primary analysis, the
survival outcomes of eligible children up to 30 Sept 2010
will be included in the analysis.
Exclusion criteria for women and children
Women and their children will be excluded from the anal-
ysis if they do not satisfy all inclusion criteria.
Methods of enumerating and interviewing women during 
baseline survey
Six mobile survey teams were trained to enumerate
women in the mapped eligible dwellings in each cluster
during the baseline survey. They recorded all eligible
women living in these dwellings, and recorded their full
birth history and child survival records. In the case of
women who are normally resident in the tabanca but not
present at the time of the baseline survey, the survey team
recorded their name and house location but did not list
their children nor record their birth history.
Methods of enumerating women in intervention arm after 
randomisation
There will be some women who are normally resident in
intervention clusters who were not enumerated during the
baseline survey. Since it would be unethical to exclude
such women from access to health clubs and the services
provided to other members of the village, they will be per-
mitted to receive the interventions. Once randomisation
is completed, the intervention team will enumerate all
households in the intervention tabancas that had not pre-
viously been enumerated, and then invite the residents to
take part in the intervention services. Only people who
live in intervention Tabancas will be permitted to receive
interventions, and women will be issued with a "mother's
card" to ensure that only women and their children who
are eligible for the interventions will receive the interven-
tions. Once this second enumeration is complete, no
additional people will be permitted to take part in the
interventions. To ensure that bias is not introduced, the
women, and their pregnancies and children, in these
households that were enumerated after randomisation
will not be included in the primary analysis of the trial.
Dealing with migration and child-swapping during the trial
The population may be affected by temporary and perma-
nent migration. Primary analysis of the outcomes of the
trial will be carried out according to the intention-to-treat
principle, i.e. women will be analysed according to
Tabanca of residence at the time of the baseline survey.
Some people in the region may practise child-swapping:
when a child stops breast-feeding, usually at 3–4 years of
age, he or she moves to live permanently with the
mother's eldest brother and is looked after by one of the
brother's wives as foster mothers. Primary analysis of the
trial will include any child permanently residing with an
eligible woman at the time of the baseline survey, regard-
less of whether the child is the offspring of the eligible
woman or not. In order to prevent possible bias, children
who become fostered by an eligible women after ran-
domisation will not be part of the trial.
Losses to follow-up
Women may temporarily move, or they may permanently
move from a tabanca, in which case we may have diffi-
culty tracking their child survival outcomes. We will try to
learn outcomes from neighbours and friends but we will
not attempt to personally interview women who have
moved outside their enumeration cluster. When an eligi-
ble woman cannot be found, we will include the informa-
tion from relatives, neighbours and other sources in the
cluster about her pregnancy and survival outcomes, and
her children's survival outcomes, for the primary analysis.
If a fieldworker did not meet with a woman in a prior
monitoring, but they do meet with her on a subsequent
visit, the field worker will ask the woman to verify the pre-
viously reported data that was received from relatives,
neighbours or other sources.
Consent
This trial will employ three levels of consent:
￿ At the state level, approval of the protocol will be
sought from the Ministry of Health in Guinea-Bissau.
￿ At the Tabanca level, field supervisors will arrange
meetings with local leaders to seek consent. In all
tabancas in the trial, consent will be obtained from the
leaders in the following manner. The local leaders will
be informed about the protocol for the trial in their
local language. They will then be asked to inform and
seek consent, as appropriate for their ethnic group and
specific traditions, from the members of their commu-
nity. Consent will be given in oral form during this
community meeting with written documentation of
the discussions for verification. This process of obtain-
ing consent from the 'guardians' of the clusters is com-
mon in trials in which the intervention is delivered at
the level of a cluster and it is not possible to ask for
prior consent for randomisation from individuals
within the cluster [11].
￿ Given this process, women who are asked to take
part in the quarterly enumeration and who consent to
complete this enumeration are considered to have
given their implied consent to participate in the trial.
Women not living in the tabancas at that point, or
who are not present, who subsequently fill the eligibil-
ity criteria will be informed about the study.BMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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Sample size calculation
The sample size has been calculated to give 80% statistical
power to show a 30% reduction in the proportion of
death before the age of five in the intervention clusters
compared to the control clusters.
We assume that the average size of the population in eli-
gible households for each cluster will be 350 people
defined by the algorithm described earlier. We also
assume an average annual number of live births of twelve
per cluster (the crude birth rate is estimated to be 35 per
1000 population in the region according to discussion
with regional health authorities). Thus, we expect to
observe approximately 48 children under five per cluster
at the time of randomisation (taking into account the esti-
mated probability of death at birth and consequent time
intervals below 5 years of age based on a baseline survey
conducted in Guinea-Bissau in preparation for this trial)
and a further 30 births during the following two and a half
years.
We used an intraclass correlation coefficient (ICC) of 0.02
to allow for clustering. This was estimated from the DHS
survey in India, using ten years data from Maharashtra
state. There are no similar DHS data for Guinea-Bissau. In
a Nepalese trial examining neonatal mortality, the ICC
was estimated to be 0.00644, but since there were gener-
ally only one or two births per woman, and the clusters in
that trial were much larger, we believe the ICC here will be
higher.
Under the above assumptions, the expected proportion of
children who will die before the age of five during a two
and a half year period in the control arm is 9%. Assuming
10% loss to follow up in both control and intervention
arms, 130 clusters in total will be needed to show a 30%
reduction in the proportion of deaths before the age of
five in the intervention clusters compared to the control
clusters with 80% statistical power and with 2-sided sig-
nificance level of 5%. We are planning to map and ran-
domise all the 146 clusters, defined as eligible during the
baseline survey, to allow for possible dilution of the
impact of the intervention that might be caused by migra-
tion.
Analysis strategies
The main analysis will assess the effect of the interven-
tions on the primary and secondary outcomes. Primary
analysis of the outcome(s) will follow the intention to
treat principle (i.e. the participants will remain in the
group they were randomised to and not analysed accord-
ing to the interventions actually received), and will
account for clustering and stratification.
For the primary outcome (proportion of children dying
before the age of 5 years), the relative risk with a 95% con-
fidence interval will be reported, taking appropriate
account of clustering. A generalised linear model (with
adjustment for stratification factors) using robust stand-
ard error estimates will be used to carry out this analysis.
For secondary binary outcomes, including morbidity,
maternal mortality and morbidity, institutional deliver-
ies, home birthing practices, relative risks will be esti-
mated in an analogous fashion. For continuous outcomes
t-tests with robust SEs will be carried out. ANCOVA (with
robust standard errors) will be used where baseline adjust-
ment is required. Bootstrapping will be used for non-nor-
mal outcomes and Cox models for survival analysis. A full
analysis plan will be given in the operations manual.
Ethical approval
The trial protocol has received ethical approval from the
Ministry of Health, Department of Hygiene and Epidemi-
ology Centre for Coordination of the Research in Guinea-
Bissau (reference number: 021/2007) as well as from the
ethics committee of the London School of Hygiene and
Tropical Medicine (reference number: 5173).
Discussion
Administrative Structure – The implementation teams
Independent service delivery and research teams will be
responsible for the implementation of interventions and
for the data collection needed to analyse the trial out-
come.
The service delivery team
The service delivery team will be responsible for imple-
menting the key components of the project, but they will
have no responsibility for data gathering or processing
used to analyse outcomes. The team will have the follow-
ing members:
Health club supervisor and trainers (3 + 22)
Three health club supervisors will monitor the trainers.
There will be 22 trainers during the first year managing an
average of six health clubs each. The trainers will be given
a 6 week training course ahead of their first health clubs.
Nurse-Trainers (9)
Health professionals will be hired to train village health
workers, and act as mentors and support for those people,
during the first year of the intervention. The mentors will
organize regular individual and group meetings with vil-
lage health workers to discuss problems, and also visit vil-
lage health workers in their community and operate
mobile clinics. They will also coordinate training for vil-
lage health workers.
Village health workers (250–300)
One to four village health workers who are resident in the
cluster and chosen by health clubs will be trained inBMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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maternal and child health. The numbers chosen will
depend on the size of the cluster and the distance needed
to travel to households within the cluster. Generally at
least one person will be trained in child health, and at
least one person will be trained in safe pregnancy, safe
delivery and care of the newborn.
Tie-ups with local clinics and hospitals
One or more reference centres will be chosen to manage
various services that may be required by children and
pregnant mothers. These services include:
￿ Services for normal and caesarean deliveries at hos-
pitals that serve the trial communities
￿ A hostel for high risk women, so that they can travel
ahead of delivery, near the hospital
￿ Primary and secondary pre and post-natal clinical
and hospital care that may be needed for pregnant
women and neonates
￿ Emergency services for children
The research team
The research team will be independent of the implemen-
tation team in this project and will be responsible for data
collection. The research team will be led by a field research
manager who will monitor the field supervisors, survey
teams, and data processors.
Field research manager and field supervisors (5)
These people will monitor survey teams and conduct ver-
bal autopsies for all reported maternal and child deaths.
They will also carry out follow-up surveys when a mother
gives birth. They will be trained to conduct verbal autop-
sies, with the assistance of a qualified doctor and to super-
vise field workers.
Survey teams (4 teams of 4 people + supervisors)
A survey team will consist of five people, with a field super-
visor and four additional members. They will be trained to
conduct quarterly monitoring surveys and manage preg-
nancy outcome forms. They will also carry out the follow-
up survey at the end of the trial.
Data processors (6)
A double entry system will be established to verify a subset
of the data entry. Cross-checks will be established to com-
pare records over time, and any problems will be flagged
and the survey teams, or data supervisors, will be respon-
sible for revisiting mothers if needed to correct the data.
Administrative structure – Trial management
The trial will be supervised by the Trial Steering Commit-
tee (TSC). The day to day activities will be the responsibil-
ity of Effective Intervention with support from the
Ministry of Health in Guinea-Bissau and the London
School of Hygiene and Tropical Medicine where appropri-
ate.
Administrative structure – Trial coordinating centre
Effective Intervention in Guinea-Bissau will act as the
local trial coordinating centre and be responsible for
recruitment, implementing interventions, and handling
administrative matters once participants are being
entered.
Administrative structure – Trial Steering Committee
The Trial Steering Committee (TSC) will meet periodically
to discuss the overall progress of the trial. The group will
meet initially to finalize the protocol and organisation.
Once the trial is running, the group will meet regularly to
discuss issues such as recruitment progress, protocol devi-
ations, and to consider reports from the Data Monitoring
Committee.
Administrative structure – The Data Monitoring 
Committee
The Data Monitoring Committee (DMC) will be com-
pletely independent of the trial and will meet regularly to
review interim results. The principal role of the DMC is to
monitor accumulating data by random allocation and
alert the organizers of the trial if they think patterns in the
data – indicating benefits, hazards or both – are suffi-
ciently persuasive to warrant either closing recruitment to
a trial or changing the protocol.
Interim analysis
Interim analyses will be pre-specified, but may be
amended if requested by the DMC. The DMC will first
assess the data when data on the outcome of child survival
in a one year period is. This interim analysis is therefore
expected to be in about one and a half years after ran-
domisation. A Peto-Haybittle rule [12,13] will be utilised
to help assess whether the trial should be stopped, but the
DMC will also take into account the balance of risk and
benefit and any relevant external evidence.
Data collection and surveillance
Initial baseline survey
The initial baseline survey will be conducted before ran-
domisation. The information from this survey will be
used to define clusters and generate lists of eligible
women and children. The survey will record birth and
child survival histories for each eligible woman.
Quarterly monitoring survey
In both arms of the trial in each cluster data will be col-
lected by the field research team on a quarterly basis.
Every eligible woman included in the trial will be inter-
viewed, and child survival histories will be updated. TheBMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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quarterly monitoring will permit measurement of the pri-
mary endpoint of the trial on an ongoing basis. Survey
teams will visit all 146 clusters approximately every three
months. They will visit each cluster for at least one full
day, and they will make multiple attempts during the day
to meet women and their children enrolled in the trial.
During this enumeration they will update child survival
outcomes for each woman, and they will record whether
the woman is pregnant. If a woman is pregnant they will
record how many months she is pregnant. If the field
worker is unable to find the woman, they will ask the
same questions to someone living in the same household,
or a neighbour, and record the information reported by
that person on child survival outcomes and pregnancy for
the missing woman. If they are unable to find a woman
during three successive quarterly visits, they will enquire
about the specific reasons for absence, and a supervisor
will follow-up and attempt to find the woman and record
data based on the responses. If it is not possible to find a
woman after nine months, then her records will be
recorded as missing from that point on, or until she can
verify her history through a direct interview.
Pregnancy outcome survey
If a woman who was previously pregnant reports she is no
longer pregnant, a brief survey will be completed to deter-
mine the outcome (termination, miscarriage, still birth,
live birth, etc.) by the research survey team.
Verbal autopsies (Maternal and child)
These surveys will be conducted by trained fieldworkers of
the research team. Three doctors will be asked to assign a
cause of death based on the findings of the field survey. A
verbal autopsy, adapted to multi-ethnic rural population
[14], will be performed whenever a mother or child dies
according to the quarterly survey outcomes. Where appro-
priate, some findings and conclusions from the verbal
autopsy will be made available to the service delivery team
in order to avoid causing distress by duplicating inter-
views about any deaths.
Follow-up survey
This in-depth survey will be conducted by the field
research team at the end of the trial. All eligible women,
or a randomly selected subset of eligible women, depend-
ing on the questions investigated, will be asked to respond
to a list of key questions relating to secondary endpoints
of the trial. The follow-up survey is only conducted once,
and at the end of the trial, in order to reduce any change
in behaviour that could result from more frequent ques-
tioning during the trial.
Village health worker survey
This survey will be completed by village health workers on
a monthly basis, with the assistance of members of the
health clubs, and will only be available in the intervention
arm of the trial. The survey will record the incidence of
symptoms of children's diseases, treatments for such
symptoms and/or evacuation, the use of specific drugs to
treat diseases, and whether evacuation of children to clin-
ics or hospitals was recommended. The outcomes from
this survey will be used by the implementation team to
analyse patterns of disease incidence that may reflect epi-
demics, the pattern of treatments for disease, the use of
drugs in a community, and the pattern of mortality. An
audit system will be developed to highlight clusters or
cases where supervisors need to investigate unusual out-
comes. VHWs will be monitored once per month by their
assigned nurse trainer. The nurse trainer will check records
and medicines distributed against stock, and will identify
children who had received them. They will select a maxi-
mum of ten treated cases at random, and conduct home
visits to check the health of the child and to interview the
mother about the treatment. All VHWs will receive an
incentive calculated from their monthly record, and from
the given feedback from their nurse trainer.
Hospital and clinic reports
The services and medicines received by pregnant women
and children in the intervention arm, from hospitals and
clinics, will be recorded by these hospitals and clinics.
A hospital care record will be completed by the nurse
trainer in the hospital, and the medical doctor in charge
will supply a medical report and record of care received.
Each case will be assessed by the clinical supervisor and
the team manager. These records will be sent to and mon-
itored in the trial coordinating centre on a monthly basis.
Membership cards of health club members
Health clubs cards will report attendance at health clubs,
along with specific data on uptake of services for pregnant
mothers and children. During the first month of the
health clubs, a "health inventory" will be compiled
including measures of children's vaccinations and indica-
tors of malnutrition. We will collect this information for
analysis; however this information will not be available in
control arms of the trial.
Monitoring health club activities and attendance
Health promoters will record when and where they have
conducted health club, as well as the number of registered
women who attended them, and hand them to their
supervisors who check that the records are completed.
They are then analysed in a monthly basis and discussed
during the monthly meetings between the programme
manager, supervisor and health promoters. In case of any
irregularities appropriate action is taken by the pro-
gramme manager. Health promoters also conduct health
knowledge checks with randomly selected registered
women in each cluster on a regular basis. They use theBMC Public Health 2009, 9:279 http://www.biomedcentral.com/1471-2458/9/279
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results at the field level to understand which key messages
may require further emphasis and explanation.
Quality control programme
The trial will use a computerised system for data manage-
ment to keep track of participants in the trial as well as for
recording the continuous flow of information to and from
participants. It will include data validation and audit trails
(detailed logs showing data which have been changed and
the reason for changing, who made the change and
when). In the process, information about adverse events,
compliance with and deviation from the protocol, docu-
mentation of losses and dropouts will be systematically
recorded. Any serious adverse event will be reported
immediately to the DMC.
Data safety and monitoring
The TSC will ensure the safety of individual patients par-
ticipating in the trial by setting up and running the trial in
accordance with good practice. Neither the TSC nor any
other team member involved with running the trial will
have sight of accumulating data by allocation during the
course of the trial.
The DMC will monitor outcomes and adverse events and
give advice to the TSC on whether to a) continue the trial
as planned, or b) stop further recruitment if there is evi-
dence that the intervention is substantially better (or
worse) than the alternatives. The DMC may also recom-
mend that the intervention be modified. Data will be
given to the DMC on a confidential basis by the trial stat-
istician. The DMC will include a biostatistician and clini-
cians with relevant expertise.
Economic evaluation and sustainability of measures post-
intervention
The project will include an analysis of cost-effectiveness
based on the actual costs and resource usage during the
trial. The direct impact of the project on lives-saved during
the first two and a half years of the trial will tend to under-
estimate the long term impact on mortality, and overesti-
mate the cost per DALYS. This is because the improved
community health knowledge and practices, along with
the improved knowledge of the village health worker, are
likely to lead to long term impacts on the community
even after training resources are withdrawn. The statistical
and economic plan will include a programme to estimate
the longer term impact of the project, and to incorporate
these in the DALYS estimates along with cost-effectiveness
analysis.
Ethics/protection of humans – research governance and 
good clinical practice
The trial will comply with all relevant legal and profes-
sional standards. These include ethics (especially protect-
ing patient confidentiality); science (ensuring research is
well designed); information (ensuring that research find-
ings are published and accessible); health and safety
(ensuring the safety of staff and participants); and finance
(being accountable for spending research funds).
Publication policy – Reporting and dissemination
Prior to their submission or application for presentation,
all manuscripts, posters or oral presentations, and other
reports of the outcomes of this research effort will be
approved by a majority of the TSC. All publications will
include a formal acknowledgement of the roles played by
Effective Intervention, LSHTM and the MOH Guinea-Bis-
sau. The primary report of the trial will follow the report-
ing guidelines in the CONSORT Statement for cluster
RCTs [15].
The authorship of manuscripts, posters, oral presenta-
tions, and any other reports of the results of this study will
be guided by the criteria for authorship formulated by the
International Committee of Medical Journal Editors as
published in its "Uniform Requirements for Manuscripts
Submitted to Biomedical Journals" [16]. According to
these requirements, the authors should meet the follow-
ing criteria: each author should have participated suffi-
ciently in the work to take public responsibility for the
content. Authorship credit should be based only on sub-
stantial contributions to (a) conception and design, or
analysis and interpretation of data; and to (b) drafting the
article or revising it critically for important intellectual
content; and on (c) final approval of the version to be
published. Conditions (a), (b), and (c) must all be met.
As a general, but not absolute, rule, at least one individual
from each of the three partner originations – Effective
Intervention, the LSHTM, MOH Guinea-Bissau – will be
authors for all publications that result from this research.
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